Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Rapamycin to Treat Fibrofolliculomas in Birt-Hogg-Dubé Syndrome

NCT00928798 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00928798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Rapamycin to Treat Fibrofolliculomas in Birt-Hogg-Dubé Syndrome
Lead sponsor
Maastricht University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2011
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

birt-hogg-dubé syndrome